{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:00:16Z","timestamp":1789390816968,"version":"build-2803163510"},"reference-count":133,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-15-1202","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T22:13:45Z","timestamp":1450390425000},"page":"289-298","source":"Crossref","is-referenced-by-count":122,"title":["The Who, What, Why, When, How and Where of Vasospastic Angina"],"prefix":"10.1253","volume":"80","author":[{"given":"John F.","family":"Beltrame","sequence":"first","affiliation":[{"name":"The Queen Elizabeth Hospital Discipline of Medicine, University of Adelaide, Central Adelaide Local Health Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Catholic University of the Sacred Heart"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Kaski","sequence":"additional","affiliation":[{"name":"Cardiovascular and Cell Sciences Research Institute, St George\u2019s, University of London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Robert-Bosch-Krankenhaus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Sechtem","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Robert-Bosch-Krankenhaus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Noel","family":"Bairey Merz","sequence":"additional","affiliation":[{"name":"Barbra Streisand Women\u2019s Heart Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Coronary Vasomotion Disorders International Study Group (COVADIS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations. <i>Int J Cardiol<\/i> 2013; 168: 934\u2013945.","DOI":"10.1016\/j.ijcard.2012.10.046"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yamanaga K, Tsujita K, Komura N, Kaikita K, Sakamoto K, Miyazaki T, et al. Single-wire pressure and flow velocity measurement for quantifying microvascular dysfunction in patients with coronary vasospastic angina. <i>Am J Physiol Heart Circ Physiol<\/i> 2015; 308: H478\u2013H484.","DOI":"10.1152\/ajpheart.00593.2014"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Radico F, Cicchitti V, Zimarino M, De Caterina R. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: Practical considerations for diagnostic tests. <i>JACC Cardiovasc Interv<\/i> 2014; 7: 453\u2013463.","DOI":"10.1016\/j.jcin.2014.01.157"},{"key":"4","unstructured":"4. Kipling R, Gleeson JM. Just so stories. Doubleday, Lane Cove, 1912; 83."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Miller D, Waters DD, Warnica W, Szlachcic J, Kreeft J, Theroux P. Is variant angina the coronary manifestation of a generalized vasospastic disorder? <i>N Engl J Med<\/i> 1981; 304: 763\u2013766.","DOI":"10.1056\/NEJM198103263041306"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nakamura Y, Shinozaki N, Hirasawa M, Kato R, Shiraishi K, Kida H, et al. Prevalence of migraine and Raynaud\u2019s phenomenon in Japanese patients with vasospastic angina. <i>Jpn Circ J<\/i> 2000; 64: 239\u2013242.","DOI":"10.1253\/jcj.64.239"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Koh KK, Kim SH, Lee KH, Kwon KS, Kim EJ, Baik SH, et al. Does prevalence of migraine and Raynaud\u2019s phenomenon also increase in Korean patients with proven variant angina? <i>Int J Cardiol<\/i> 1995; 51: 37\u201346.","DOI":"10.1016\/0167-5273(95)02371-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Di Fiore DP, Zeitz CJ, Arstall MA, Rajendran S, Sheikh AR, Beltrame JF. Clinical determinants of acetylcholine-induced coronary artery spasm in Australian patients. <i>Int J Cardiol<\/i> 2015; 193: 59\u201361.","DOI":"10.1016\/j.ijcard.2015.05.058"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Scholl JM, Benacerraf A, Ducimetiere P, Chabas D, Brau J, Chapelle J, et al. Comparison of risk factors in vasospastic angina without significant fixed coronary narrowing to significant fixed coronary narrowing and no vasospastic angina. <i>Am J Cardiol<\/i> 1986; 57: 199\u2013202.","DOI":"10.1016\/0002-9149(86)90890-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. <i>Circulation<\/i> 1993; 87: 76\u201379.","DOI":"10.1161\/01.CIR.87.1.76"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Takaoka K, Yoshimura M, Ogawa H, Kugiyama K, Nakayama M, Shimasaki Y, et al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: Role of cigarette smoking. <i>Int J Cardiol<\/i> 2000; 72: 121\u2013126.","DOI":"10.1016\/S0167-5273(99)00172-2"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Sato K, Kaikita K, Nakayama N, Horio E, Yoshimura H, Ono T, et al. Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: Analysis of a single-center study over 20 years. <i>J Am Heart Assoc<\/i> 2013; 2: e000227, doi:10.1161\/JAHA.113.000227.","DOI":"10.1161\/JAHA.113.000227"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nobuyoshi M, Abe M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, et al. Statistical analysis of clinical risk factors for coronary artery spasm: Identification of the most important determinant. <i>Am Heart J<\/i> 1992; 124: 32\u201338.","DOI":"10.1016\/0002-8703(92)90917-K"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Maouad J, Fernandez F, Hebert JL, Zamani K, Barrillon A, Gay J. Cigarette smoking during coronary angiography: Diffuse or focal narrowing (spasm) of the coronary arteries in 13 patients with angina at rest and normal coronary angiograms. <i>Cathet Cardiovasc Diagn<\/i> 1986; 12: 366\u2013375.","DOI":"10.1002\/ccd.1810120603"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Miwa K, Fujita M, Miyagi Y, Inoue H, Sasayama S. High-density lipoprotein cholesterol level and smoking modify the prognosis of patients with coronary vasospasm. <i>Clin Cardiol<\/i> 1995; 18: 267\u2013272.","DOI":"10.1002\/clc.4960180508"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. <i>Circulation<\/i> 2000; 101: 1102\u20131108.","DOI":"10.1161\/01.CIR.101.10.1102"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2013): Digest version. <i>Circ J<\/i> 2014; 78: 2779\u20132801.","DOI":"10.1253\/circj.CJ-66-0098"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): Digest version. <i>Circ J<\/i> 2010; 74: 1745\u20131762.","DOI":"10.1253\/circj.CJ-10-74-0802"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, et al. International standardization of diagnostic criteria for vasospastic angina. <i>Eur Heart J<\/i>2015 August 5, doi:10.1093\/eurheartj\/ehv351.","DOI":"10.1093\/eurheartj\/ehv351"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. <i>Am J Med<\/i> 1959; 27: 375\u2013388.","DOI":"10.1016\/0002-9343(59)90003-8"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lanza GA, Sestito A, Sgueglia GA, Infusino F, Manolfi M, Crea F, et al. Current clinical features, diagnostic assessment and prognostic determinants of patients with variant angina. <i>Int J Cardiol<\/i> 2007; 118: 41\u201347.","DOI":"10.1016\/j.ijcard.2006.06.016"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. <i>J Am Coll Cardiol<\/i> 1999; 33: 1442\u20131452.","DOI":"10.1016\/S0735-1097(99)00073-X"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ong P, Athanasiadis A, Borgulya G, Voehringer M, Sechtem U. 3-year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: The CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up. <i>J Am Coll Cardiol<\/i> 2011; 57: 147\u2013152.","DOI":"10.1016\/j.jacc.2010.08.626"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Takagi Y, Takahashi J, Yasuda S, Miyata S, Tsunoda R, Ogata Y, et al. Prognostic stratification of patients with vasospastic angina: A comprehensive clinical risk score developed by the Japanese coronary spasm association. <i>J Am Coll Cardiol<\/i> 2013; 62: 1144\u20131153.","DOI":"10.1016\/j.jacc.2013.07.018"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Fukai T, Koyanagi S, Takeshita A. Role of coronary vasospasm in the pathogenesis of myocardial infarction: Study in patients with no significant coronary stenosis. <i>Am Heart J<\/i> 1993; 126: 1305\u20131311.","DOI":"10.1016\/0002-8703(93)90527-G"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Da Costa A, Isaaz K, Faure E, Mourot S, Cerisier A, Lamaud M. Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction with an absolutely normal coronary angiogram; a 3-year follow-up study of 91 patients. <i>Eur Heart J<\/i> 2001; 22: 1459\u20131465.","DOI":"10.1053\/euhj.2000.2553"},{"key":"27","unstructured":"27. Canavy I, Dutrillat C, Garcia E, Bonnet JL, Bory M. Prospective study on the mechanism of myocardial infarction without significant coronary stenosis. <i>Arch Mal Coeur Vaiss<\/i> 1999; 92: 225\u2013233 (in French)."},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Nakayama N, Kaikita K, Fukunaga T, Matsuzawa Y, Sato K, Horio E, et al. Clinical features and prognosis of patients with coronary spasm-induced non-ST-segment elevation acute coronary syndrome. <i>J Am Heart Assoc<\/i> 2014; 3: e000795, doi:10.1161\/JAHA.114.000795.","DOI":"10.1161\/JAHA.114.000795"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U. Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. <i>J Am Coll Cardiol<\/i> 2008; 52: 523\u2013527.","DOI":"10.1016\/j.jacc.2008.04.050"},{"key":"30","unstructured":"30. Igarashi Y, Tamura Y, Tanabe Y, Fujita T, Yamazoe M, Shibata A. Angina-linked syncope and lack of calcium antagonist therapy predict cardiac arrest before definitive diagnosis of vasospastic angina. <i>Coron Artery Dis<\/i> 1994; 5: 881\u2013887."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Igarashi Y, Tamura Y, Suzuki K, Tanabe Y, Yamaguchi T, Fujita T, et al. Coronary artery spasm is a major cause of sudden cardiac arrest in survivors without underlying heart disease. <i>Coron Artery Dis<\/i> 1993 4: 177\u2013185.","DOI":"10.1097\/00019501-199302000-00008"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kawana A, Takahashi J, Takagi Y, Yasuda S, Sakata Y, Tsunoda R, et al. Gender differences in the clinical characteristics and outcomes of patients with vasospastic angina: A report from the Japanese Coronary Spasm Association. <i>Circ J<\/i> 2013; 77: 1267\u20131274.","DOI":"10.1253\/circj.CJ-12-1486"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-term prognosis for patients with variant angina and influential factors. <i>Circulation<\/i> 1988; 78: 1\u20139.","DOI":"10.1161\/01.CIR.78.1.1"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Maseri A, Beltrame JF, Shimokawa H. Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets. <i>Circ J<\/i> 2009; 73: 394\u2013403.","DOI":"10.1253\/circj.CJ-09-0033"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Bentivoglio L, Gruntzig A. Relief by intracoronary glyceryl trinitrate of coronary artery spasm resistant to sublingual route of administration. <i>Br Heart J<\/i> 1981; 46: 581\u2013583.","DOI":"10.1136\/hrt.46.5.581"},{"key":"36","unstructured":"36. Przybojewski J. The importance of excluding coronary artery vasospasm before percutaneous transluminal coronary angioplasty: A case report. <i>S Afr Med J<\/i> 1986; 70: 495\u2013499."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Hanratty CG, Koyama Y, Rasmussen HH, Nelson GI, Hansen PS, Ward MR. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: Implications for immediate multivessel revascularization. <i>J Am Coll Cardiol<\/i> 2002; 40: 911\u2013916.","DOI":"10.1016\/S0735-1097(02)02049-1"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. <i>Eur Heart J<\/i> 2013; 34: 2949\u20133003.","DOI":"10.1093\/eurheartj\/eht296"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Robertson RM, Wood AJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. <i>Circulation<\/i> 1982; 65: 281\u2013285.","DOI":"10.1161\/01.CIR.65.2.281"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Zaya M, Mehta PK, Bairey Merz CN. Provocative testing for coronary reactivity and spasm. <i>J Am Coll Cardiol<\/i> 2014; 63: 103\u2013109.","DOI":"10.1016\/j.jacc.2013.10.038"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Nakao K, Ohgushi M, Yoshimura M, Morooka K, Okumura K, Ogawa H, et al. Hyperventilation as a specific test for diagnosis of coronary artery spasm. <i>Am J Cardiol<\/i> 1997; 80: 545\u2013549.","DOI":"10.1016\/S0002-9149(97)00419-0"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Song JK, Lee SJ, Kang DH, Cheong SS, Hong MK, Kim JJ, et al. Ergonovine echocardiography as a screening test for diagnosis of vasospastic angina before coronary angiography. <i>J Am Coll Cardiol<\/i> 1996; 27: 1156\u20131161.","DOI":"10.1016\/0735-1097(95)00590-0"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Heupler FA Jr, Proudfit WL, Razavi M, Shirey EK, Greenstreet R, Sheldon WC. Ergonovine maleate provocative test for coronary arterial spasm. <i>Am J Cardiol<\/i> 1978; 41: 631\u2013640.","DOI":"10.1016\/0002-9149(78)90810-X"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H, et al. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. <i>J Am Coll Cardiol<\/i> 1988; 12: 883\u2013888.","DOI":"10.1016\/0735-1097(88)90449-4"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Curry RC Jr, Pepine CJ, Sabom MB, Conti CR. Similarities of ergonovine-induced and spontaneous attacks of variant angina. <i>Circulation<\/i> 1979; 59: 307\u2013314.","DOI":"10.1161\/01.CIR.59.2.307"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Ozaki Y, Takatsu F, Osugi J, Sugiishi M, Watarai M, Anno T, et al. Long-term study of recurrent vasospastic angina using coronary angiograms during ergonovine provocation tests. <i>Am Heart J<\/i> 1992; 123: 1191\u20131198.","DOI":"10.1016\/0002-8703(92)91022-S"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Shin DI, Baek SH, Her SH, Han SH, Ahn Y, Park KH, et al. The 24-month prognosis of patients with positive or intermediate results in the intracoronary ergonovine provocation test. <i>JACC Cardiovasc Interv<\/i> 2015; 8: 914\u2013923.","DOI":"10.1016\/j.jcin.2014.12.249"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Buxton A, Goldberg S, Hirshfeld JW, Wilson J, Mann T, Williams DO, et al. Refractory ergonovine-induced coronary vasospasm: Importance of intracoronary nitroglycerin. <i>Am J Cardiol<\/i> 1980; 46: 329\u2013334.","DOI":"10.1016\/0002-9149(80)90080-6"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Ong P, Athanasiadis A, Borgulya G, Vokshi I, Bastiaenen R, Kubik S, et al. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. <i>Circulation<\/i> 2014; 129: 1723\u20131730.","DOI":"10.1161\/CIRCULATIONAHA.113.004096"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Takagi Y, Yasuda S, Takahashi J, Tsunoda R, Ogata Y, Seki A, et al. Clinical implications of provocation tests for coronary artery spasm: Safety, arrhythmic complications, and prognostic impact: Multicentre registry study of the Japanese Coronary Spasm Association. <i>Eur Heart J<\/i> 2013; 34: 258\u2013267.","DOI":"10.1093\/eurheartj\/ehs199"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Sueda S, Saeki H, Otani T, Mineoi K, Kondou T, Yano K, et al. Major complications during spasm provocation tests with an intracoronary injection of acetylcholine. <i>Am J Cardiol<\/i> 2000; 85: 391\u2013394, A310.","DOI":"10.1016\/S0002-9149(99)00754-7"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Wei J, Mehta PK, Johnson BD, Samuels B, Kar S, Anderson RD, et al. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: Results from the NHLBI-sponsored WISE (Women\u2019s Ischemia Syndrome Evaluation) study. <i>JACC Cardiovasc Interv<\/i> 2012; 5: 646\u2013653.","DOI":"10.1016\/j.jcin.2012.01.023"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Miwa K, Fujita M, Miyagi Y. Beneficial effects of smoking cessation on the short-term prognosis for variant angina: Validation of the smoking status by urinary cotinine measurements. <i>Int J Cardiol<\/i> 1994; 44: 151\u2013156.","DOI":"10.1016\/0167-5273(94)90019-1"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Morikawa Y, Mizuno Y, Harada E, Katoh D, Kashiwagi Y, Morita S, et al. Aerobic interval exercise training in the afternoon reduces attacks of coronary spastic angina in conjunction with improvement in endothelial function, oxidative stress, and inflammation. <i>Coron Artery Dis<\/i> 2013; 24: 177\u2013182.","DOI":"10.1097\/MCA.0b013e32835cbef5"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. <i>J Am Coll Cardiol<\/i> 2008; 51: 1742\u20131748.","DOI":"10.1016\/j.jacc.2007.12.049"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Johnson S, Mauritson D, Willerson J, Hillis L. A controlled trial of verapamil for Prinzmetal\u2019s variant angina. <i>N Engl J Med<\/i> 1981; 304: 862\u2013866.","DOI":"10.1056\/NEJM198104093041502"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Ginsburg R, Lamb I, Schroeder J, Hu M, Harrison D. Randomized double-blind comparison of nifedipine and isosorbide dinitrate therapy in variant angina pectoris due to coronary artery spasm. <i>Am Heart J<\/i> 1982; 103: 44\u201349.","DOI":"10.1016\/0002-8703(82)90527-0"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Antman E, Muller J, Goldberg S, MacAlpin R, Rubenfire M, Tabatznik B, et al. Nifedipine therapy for coronary-artery spasm: Experience in 127 patients. <i>N Engl J Med<\/i> 1980; 302: 1269\u20131273.","DOI":"10.1056\/NEJM198006053022301"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Chahine RA, Feldman RL, Giles TD, Nicod P, Raizner AE, Weiss RJ, et al. Randomised placebo-controlled trial of amlodipine in vasospastic angina. <i>J Am Coll Cardiol<\/i> 1993; 21: 1365\u20131370.","DOI":"10.1016\/0735-1097(93)90310-W"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Goldberg S, Reichek N, Wilson J, Hirshfeld JW Jr, Muller J, Kastor JA. Nifedipine in the treatment of Prinzmetal\u2019s (variant) angina. <i>Am J Cardiol<\/i> 1979; 44: 804\u2013810.","DOI":"10.1016\/0002-9149(79)90201-7"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Heupler FJ, Proudfit W. Nifedipine therapy for refractory coronary arterial spasm. <i>Am J Cardiol<\/i> 1979; 44: 798\u2013803.","DOI":"10.1016\/0002-9149(79)90200-5"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Higuma T, Oikawa K, Kato T, Mori Y, Kudo T, Yamamoto T, et al. Comparison of the effects of long-acting nifedipine CR and diltiazem R in patients with vasospastic angina: Aomori coronary spastic angina study. <i>J Cardiol<\/i> 2010; 56: 354\u2013360.","DOI":"10.1016\/j.jjcc.2010.07.010"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Nishigaki K, Inoue Y, Yamanouchi Y, Fukumoto Y, Yasuda S, Sueda S, et al. Prognostic effects of calcium channel blockers in patients with vasospastic angina. <i>Circ J<\/i> 2010; 74: 1943\u20131950.","DOI":"10.1253\/circj.CJ-10-0292"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Takahashi J, Nihei T, Takagi Y, Miyata S, Odaka Y, Tsunoda R, et al. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: Multicentre registry study of the Japanese coronary spasm association. <i>Eur Heart J<\/i> 2015; 36: 228\u2013237.","DOI":"10.1093\/eurheartj\/ehu313"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Kosugi M, Nakagomi A, Shibui T, Kato K, Kusama Y, Atarashi H, et al. Effect of long-term nitrate treatment on cardiac events in patients with vasospastic angina. <i>Circ J<\/i> 2011; 75: 2196\u20132205.","DOI":"10.1253\/circj.CJ-11-0056"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Aizawa T, Ogasawara K, Nakamura F, Hirosaka A, Sakuma T, Nagashima K, et al. Effect of nicorandil on coronary spasm. <i>Am J Cardiol<\/i> 1989; 63: 75J\u201379J.","DOI":"10.1016\/0002-9149(89)90210-5"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Lablanche JM, Bauters C, Leroy F, Bertrand ME. Prevention of coronary spasm by nicorandil: Comparison with nifedipine. <i>J Cardiovasc Pharmacol<\/i> 1992; 20: 82\u201385.","DOI":"10.1097\/00005344-199206203-00014"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Kishida H, Murao S. Effect of a new coronary vasodilator, nicorandil, on variant angina pectoris. <i>Clin Pharmacol Ther<\/i> 1987; 42: 166\u2013174.","DOI":"10.1038\/clpt.1987.127"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Shimokawa H. 2014 Williams Harvey Lecture: Importance of coronary vasomotion abnormalities-from bench to bedside. <i>Eur Heart J<\/i> 2014; 35: 3180\u20133193.","DOI":"10.1093\/eurheartj\/ehu427"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Nihei T, Takahashi J, Tsuburaya R, Ito Y, Shiroto T, Hao K, et al. Circadian variation of Rho-kinase activity in circulating leukocytes of patients with vasospastic angina. <i>Circ J<\/i> 2014; 78: 1183\u20131190.","DOI":"10.1253\/circj.CJ-13-1458"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Inokuchi K, Ito A, Fukumoto Y, Matoba T, Shiose A, Nishida T, et al. Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery. <i>J Cardiovasc Pharmacol<\/i> 2004; 44: 275\u2013277.","DOI":"10.1097\/01.fjc.0000134775.76636.3f"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. <i>Circulation<\/i> 2002; 105: 1545\u20131547.","DOI":"10.1161\/hc1002.105938"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Shin ES, Lee JH, Yoo SY, Park Y, Hong YJ, Kim MH, et al. A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina. <i>Heart<\/i> 2014; 100: 1531\u20131536.","DOI":"10.1136\/heartjnl-2014-305986"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Morita S, Mizuno Y, Harada E, Kashiwagi Y, Yoshimura M, Murohara T, et al. Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, suppresses coronary spasm. <i>Coron Artery Dis<\/i> 2014; 25: 671\u2013677.","DOI":"10.1097\/MCA.0000000000000144"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Miyagi H, Yasue H, Okumura K, Ogawa H, Goto K, Oshima S. Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. <i>Circulation<\/i> 1989; 79: 597\u2013602.","DOI":"10.1161\/01.CIR.79.3.597"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Kawano H, Motoyama T, Hirai N, Kugiyama K, Ogawa H, Yasue H. Estradiol supplementation suppresses hyperventilation-induced attacks in postmenopausal women with variant angina. <i>J Am Coll Cardiol<\/i> 2001; 37: 735\u2013740.","DOI":"10.1016\/S0735-1097(00)01187-6"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Kugiyama K, Motoyama T, Hirashima O, Ohgushi M, Soejima H, Misumi K, et al. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. <i>J Am Coll Cardiol<\/i> 1998; 32: 103\u2013109.","DOI":"10.1016\/S0735-1097(98)00185-5"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Kern MJ, Ganz P, Horowitz JD, Gaspar J, Barry WH, Lorell BH, et al. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. <i>Circulation<\/i> 1983; 67: 1178\u20131185.","DOI":"10.1161\/01.CIR.67.6.1178"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Ito A, Fukumoto Y, Shimokawa H. Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. <i>J Cardiovasc Pharmacol<\/i> 2004; 44: 480\u2013485.","DOI":"10.1097\/01.fjc.0000141473.29254.62"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Akkus NI, Rajpal S, Peter E. Resolution of nebivolol-induced coronary vasospasm by intracoronary nitroglycerin during a coronary angiogram. <i>Rev Port Cardiol<\/i> 2012; 31: 825\u2013828.","DOI":"10.1016\/j.repc.2012.04.016"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Koh K, Roe I, Lee M, Cho S, Kim S. Variant angina complicating ergot therapy of migraine. <i>Chest<\/i> 1994; 105: 1259\u20131260.","DOI":"10.1378\/chest.105.4.1259"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Santoro F, Spennati G, Ieva R, De Gennaro L, Correale M, Lopizzo A, et al. Late onset of coronary vasospasm after administration of methyl-ergometrine for gynecologic bleeding. <i>Int J Cardiol<\/i> 2012; 161: 29\u201330.","DOI":"10.1016\/j.ijcard.2012.03.156"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Janjua M, Badshah A, Allen SA. Images in cardiology. Epinephrine-induced ST elevation: A case of endobronchial topical epinephrine-induced coronary vasospasm. <i>Heart<\/i> 2009; 95: 656.","DOI":"10.1136\/hrt.2008.161646"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Karch SB. Coronary artery spasm induced by intravenous epinephrine overdose. <i>Am J Emerg Med<\/i> 1989; 7: 485\u2013488.","DOI":"10.1016\/0735-6757(89)90250-7"},{"key":"85","unstructured":"85. Yildirim AB, Basarici I, Kucuk M. Recurrent ventricular arrhythmias and myocardial infarctions associated with cocaine induced reversible coronary vasospasm. <i>Cardiol J<\/i> 2010; 17: 512\u2013517."},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Mueller L, Gallagher RM, Ciervo CA. Vasospasm-induced myocardial infarction with sumatriptan. <i>Headache<\/i> 1996; 36: 329\u2013331.","DOI":"10.1046\/j.1526-4610.1996.3605329.x"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Chalaupka FD. Acute myocardial infarction with sumatriptan: A case report and review of the literature. <i>Headache<\/i> 2009; 49: 762\u2013764.","DOI":"10.1111\/j.1526-4610.2009.01409.x"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Shimizu M, Hata K, Takaoka H, Kanazawa K, Shinke T, Matsumoto H, et al. Sumatriptan provokes coronary artery spasm in patients with variant angina: Possible involvement of serotonin 1B receptor. <i>Int J Cardiol<\/i> 2007; 114: 188\u2013194.","DOI":"10.1016\/j.ijcard.2006.01.026"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Willett F, Curzen N, Adams J, Armitage M. Coronary vasospasm induced by subcutaneous sumatriptan. <i>Br Med J<\/i> 1992; 304: 1415.","DOI":"10.1136\/bmj.304.6839.1415"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Sidi A, Dahleen L, Gaspardone A. Coronary vasospasm during anesthesia induction: Awareness, recognition, possible mechanisms, anesthetic factors, and treatment. <i>J Clin Anesth<\/i> 2008; 20: 64\u201369.","DOI":"10.1016\/j.jclinane.2007.02.016"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Soto E, Duvernoy W, David S, Small D, Nair M. Coronary artery spasm induced by anesthesia: A case report and review of the literature. <i>Clin Cardiol<\/i> 1990; 13: 59\u201361.","DOI":"10.1002\/clc.4960130111"},{"key":"92","unstructured":"92. Himuro H, Aono K, Honda T, Nakajima T, Ohara G. A case of coronary artery spasm during oral surgery under general anesthesia. <i>Anesth Pain Control Dent<\/i> 1992; 4: 215\u2013218."},{"key":"93","unstructured":"93. Fradley MG, Barrett CD, Clark JR, Francis SA. Ventricular fibrillation cardiac arrest due to 5-fluorouracil cardiotoxicity. <i>Tex Heart Inst J<\/i> 2013; 40: 472\u2013476."},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Sorrentino MF, Kim J, Foderaro AE, Truesdell AG. 5-fluorouracil induced cardiotoxicity: Review of the literature. <i>Cardiol J<\/i> 2012; 19: 453\u2013458.","DOI":"10.5603\/CJ.2012.0084"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Maseri A, Lanza G. Fluorouracil-induced coronary artery spasm. <i>Am J Med<\/i> 2001; 111: 326\u2013327.","DOI":"10.1016\/S0002-9343(01)00930-5"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Goldsmith YB, Roistacher N, Baum MS. Capecitabine-induced coronary vasospasm. <i>J Clin Oncol<\/i> 2008; 26: 3802\u20133804.","DOI":"10.1200\/JCO.2008.17.1637"},{"key":"97","unstructured":"97. Tsiamis E, Synetos A, Stefanadis C. Capecitabine may induce coronary artery vasospasm. <i>Hellenic J Cardiol<\/i> 2012; 53: 320\u2013323."},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Arima Y, Oshima S, Noda K, Fukushima H, Taniguchi I, Nakamura S, et al. Sorafenib-induced acute myocardial infarction due to coronary artery spasm. <i>J Cardiol<\/i> 2009; 54: 512\u2013515.","DOI":"10.1016\/j.jjcc.2009.03.009"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Porto I, Leo A, Miele L, Pompili M, Landolfi R, Crea F. A case of variant angina in a patient under chronic treatment with sorafenib. <i>Nat Rev Clin Oncol<\/i> 2010; 7: 476\u2013480.","DOI":"10.1038\/nrclinonc.2010.67"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. Takizawa A, Yasue H, Omote S, Nagao M, Hyon H, Nishida S, et al. Variant angina induced by alcohol ingestion. <i>Am Heart J<\/i> 1984; 107: 25\u201327.","DOI":"10.1016\/0002-8703(84)90128-5"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Kashima T, Tanaka H, Arikawa K, Ariyama T. Variant angina induced by alcohol ingestion. <i>Angiology<\/i> 1982; 33: 137\u2013139.","DOI":"10.1177\/000331978203300210"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Oda H, Suzuki M, Oniki T, Kishi Y, Numano F. Alcohol and coronary spasm. <i>Angiology<\/i> 1994; 45: 187\u2013197.","DOI":"10.1177\/000331979404500303"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. Tanabe Y, Yamazoe M, Igarashi Y, Tamura Y, Tsuchida K, Otsuka K, et al. Importance of coronary artery spasm in alcohol-related unexplained syncope. <i>Jpn Heart J<\/i> 1992; 33: 135\u2013144.","DOI":"10.1536\/ihj.33.135"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. Matsuguchi T, Araki H, Nakamura N, Etoh Y, Okamatsu S, Takeshita A, et al. Prevention of vasospastic angina by alcohol ingestion: Report of 2 cases. <i>Angiology<\/i> 1988; 39: 394\u2013400.","DOI":"10.1177\/000331978803900412"},{"key":"105","unstructured":"105. Tanabe K, Nanke T, Nakazawa A, Miyake F, Mikawa T, Murayama M, et al. Inhibition of vasospastic angina by alcohol ingestion. <i>Kokyu To Junkan<\/i> 1990; 38: 919\u2013923 (in Japanese)."},{"key":"106","doi-asserted-by":"crossref","unstructured":"106. Pijls N, van der Werf T. Prinzmetal\u2019s angina associated with alcohol withdrawal. <i>Cardiology<\/i> 1988; 75: 226\u2013229.","DOI":"10.1159\/000174376"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. Mizuno Y, Harada E, Morita S, Kinoshita K, Hayashida M, Shono M, et al. East asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: Possible roles of reactive aldehydes and implications of alcohol flushing syndrome. <i>Circulation<\/i> 2015; 131: 1665\u20131673.","DOI":"10.1161\/CIRCULATIONAHA.114.013120"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108. Bertrand ME, LaBlanche JM, Thieuleux FA, Fourrier JL, Traisnel G, Asseman P. Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis. <i>J Am Coll Cardiol<\/i> 1986; 8: 504\u2013508.","DOI":"10.1016\/S0735-1097(86)80174-7"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109. David P, Waters D, Scholl J, Crepeau J, Szlachcic J, Lesperance J, et al. Percutaneous transluminal coronary angioplasty in patients with variant angina. <i>Circulation<\/i> 1982; 66: 695\u2013702.","DOI":"10.1161\/01.CIR.66.4.695"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110. Leisch F, Harringer W, Kerschner K, Hofmann R, Feirer G, Schutzenberger W. Importance of coronary spasm for recurrences following percutaneous transluminal coronary angioplasty (PTCA). <i>Eur Heart J<\/i> 1991; 12: 1029\u20131033.","DOI":"10.1093\/eurheartj\/12.9.1029"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111. Sueda S, Suzuki J, Watanabe K, Mineoi K, Kondou T, Yano K, et al. Comparative results of coronary intervention in patients with variant angina versus those with non-variant angina. <i>Jpn Heart J<\/i> 2001; 42: 657\u2013667.","DOI":"10.1536\/jhj.42.657"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112. Tanabe Y, Itoh E, Suzuki K, Ito M, Hosaka Y, Nakagawa I, et al. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. <i>J Am Coll Cardiol<\/i> 2002; 39: 1120\u20131126.","DOI":"10.1016\/S0735-1097(02)01746-1"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113. Hastey CE, Erwin SW, Ramanathan KB. Ergonovine-induced coronary spasm refractory to intracoronary nitroglycerin but responsive to nitroprusside. <i>Am Heart J<\/i> 1984; 107: 778\u2013781.","DOI":"10.1016\/0002-8703(84)90328-4"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114. Babbitt D, Perry J, Forman M. Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angioplasty. <i>J Am Coll Cardiol<\/i> 1988; 12: 1377\u20131381.","DOI":"10.1016\/0735-1097(88)92623-X"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115. Phaneuf DC, Waters DD, Dauwe F, Theroux P, Pelletier G, Mizgala HF. Refractory variant angina controlled with combined drug therapy in a patient with a single coronary artery. <i>Cathet Cardiovasc Diagn<\/i> 1980; 6: 413\u2013421.","DOI":"10.1002\/ccd.1810060410"},{"key":"116","unstructured":"116. Maseri A. Variant angina. <i>In<\/i>: Ischemic heart disease. A rational basis for clinical practise and clinical research. New York: Churchill Livingstone; 1995: 559\u2013588."},{"key":"117","doi-asserted-by":"crossref","unstructured":"117. Frenneaux M, Kaski JC, Brown M, Maseri A. Refractory variant angina relieved by guanethidine and clonidine. <i>Am J Cardiol<\/i> 1988; 62: 832\u2013833.","DOI":"10.1016\/0002-9149(88)91238-6"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118. Takagi S, Goto Y, Hirose E, Terashima M, Sakuragi S, Suzuki S, et al. Successful treatment of refractory vasospastic angina with corticosteroids: Coronary arterial hyperactivity caused by local inflammation? <i>Circ J<\/i> 2004; 68: 17\u201322.","DOI":"10.1253\/circj.68.17"},{"key":"119","doi-asserted-by":"publisher","unstructured":"119. Dominguez Franco AJ, Gomez Doblas JJ, Garcia Pinilla JM, Hernandez Garcia JM, Jimenez Navarro M, Alonso Briales JH, et al. Treatment of refractory vasoespastic angina with corticosteroids: A case report. <i>Int J Cardiol<\/i> 2007; 118: e51\u2013e53, doi:10.1016\/j.ijcard.2006.12.058.","DOI":"10.1016\/j.ijcard.2006.12.058"},{"key":"120","doi-asserted-by":"crossref","unstructured":"120. Abbate A, Hamza M, Cassano AD, Melchior R, Roberts C, Grizzard J, et al. Sympathectomy as a treatment for refractory coronary artery spasm. <i>Int J Cardiol<\/i> 2012; 161: 7\u20139.","DOI":"10.1016\/j.ijcard.2012.03.006"},{"key":"121","doi-asserted-by":"crossref","unstructured":"121. Chu G, Zhang G, Zhang Z, Liu S, Wen Q, Sun B. Clinical outcome of coronary stenting in patients with variant angina refractory to medical treatment: A consecutive single-center analysis. <i>Med Princ Pract<\/i> 2013; 22: 583\u2013587.","DOI":"10.1159\/000354290"},{"key":"122","doi-asserted-by":"crossref","unstructured":"122. Gaspardone A, Tomai F, Versaci F, Ghini AS, Polisca P, Crea F, et al. Coronary artery stent placement in patients with variant angina refractory to medical treatment. <i>Am J Cardiol<\/i> 1999; 84: 96\u201398, A98.","DOI":"10.1016\/S0002-9149(99)00201-5"},{"key":"123","doi-asserted-by":"crossref","unstructured":"123. Jeong MH, Park JC, Rhew JY, Kang KT, Lee SH, Cho JH, et al. Successful management of intractable coronary spasm with a coronary stent. <i>Jpn Circ J<\/i> 2000; 64: 897\u2013900.","DOI":"10.1253\/jcj.64.897"},{"key":"124","doi-asserted-by":"crossref","unstructured":"124. Khatri S, Webb JG, Carere RG, Dodek A. Stenting for coronary artery spasm. <i>Catheter Cardiovasc Interv<\/i> 2002; 56: 16\u201320.","DOI":"10.1002\/ccd.10170"},{"key":"125","doi-asserted-by":"crossref","unstructured":"125. Kultursay H, Can L, Payzin S, Turkoglu C, Altintig A, Akin M, et al. A rare indication for stenting: Persistent coronary artery spasm. <i>Heart Vessels<\/i> 1996; 11: 165\u2013168.","DOI":"10.1007\/BF01745175"},{"key":"126","doi-asserted-by":"crossref","unstructured":"126. Lopez J, Angelini P, Leachman D, Lufschanowski R. Gianturco-Roubin stent placement for variant angina refractory to medical treatment. <i>Cathet Cardiovasc Diagn<\/i> 1994; 33: 161\u2013165.","DOI":"10.1002\/ccd.1810330217"},{"key":"127","unstructured":"127. Serrador A, Roman JA, Duran JM, Gimeno F, Vega JL, Fernandez-Aviles F. Successful treatment of vasospastic angina with a coronary stent. <i>J Invasive Cardiol<\/i> 2000; 12: 586\u2013588."},{"key":"128","unstructured":"128. Sugimoto A, Morino Y, Ikari Y. Stent implantation for diffuse and multiple coronary spasm in a patient with variant angina refractory to optimal medical therapy. <i>J Invasive Cardiol<\/i> 2007; 19: 320\u2013323."},{"key":"129","doi-asserted-by":"crossref","unstructured":"129. Clark D, Quint R, Mitchell R, Dugell W. Coronary artery spasm: Medical manangement, surgical denervation and autotransplantation. <i>J Thorac Cardiovasc Surg<\/i> 1977; 73: 332\u2013339.","DOI":"10.1016\/S0022-5223(19)39910-6"},{"key":"130","unstructured":"130. Bertrand M, Lablanche J, Tilmant P, Thieuleux F, Ducloux G, Godin J, et al. Treatment of a severe coronary artery spasm, refractory to complete denervation of the heart (autotransplantation). <i>Arch Mal Coeur Vaiss<\/i> 1982; 75: 717\u2013723 (in French)."},{"key":"131","doi-asserted-by":"crossref","unstructured":"131. Ong P, Aziz A, Hansen HS, Prescott E, Athanasiadis A, Sechtem U. Structural and functional coronary artery abnormalities in patients with vasospastic angina pectoris. <i>Circ J<\/i> 2015; 79: 1431\u20131438.","DOI":"10.1253\/circj.CJ-15-0520"},{"key":"132","doi-asserted-by":"crossref","unstructured":"132. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: Lessons from animal models. <i>Jpn Circ J<\/i> 2000; 64: 1\u201312.","DOI":"10.1253\/jcj.64.1"},{"key":"133","doi-asserted-by":"crossref","unstructured":"133. Sueda S, Kohno H, Fukuda H, Watanabe K, Ochi N, Kawada H, et al. Limitations of medical therapy in patients with pure coronary spastic angina. <i>Chest<\/i> 2003; 123: 380\u2013386.","DOI":"10.1378\/chest.123.2.380"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/2\/80_CJ-15-1202\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T22:09:58Z","timestamp":1599948598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/2\/80_CJ-15-1202\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-15-1202","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}